-
1
-
-
84866614844
-
Serogroup A meningococcal conjugate-vaccination in Burkina Faso: Analysis of national surveillance data
-
Novak RT, Kambou JL, Diomandé FVK, et al. Serogroup A meningococcal conjugate-vaccination in Burkina Faso: Analysis of national surveillance data. Lancet Infect Dis 2012;12:757-64.
-
(2012)
Lancet Infect Dis
, vol.12
, pp. 757-764
-
-
Novak, R.T.1
Kambou, J.L.2
Diomandé, F.V.K.3
-
2
-
-
3242768475
-
Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction
-
DOI 10.1016/S0140-6736(04)16725-1, PII S0140673604167251
-
Trotter CL, Andrews NJ, Kaczmarski EB, Miller E, Ramsay ME. Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction. Lancet 2004;364:365-7. (Pubitemid 38970013)
-
(2004)
Lancet
, vol.364
, Issue.9431
, pp. 365-367
-
-
Trotter, C.L.1
Andrews, N.J.2
Kaczmarski, E.B.3
Miller, E.4
Ramsay, M.E.5
-
3
-
-
34250801673
-
An advisory committee statement (ACS) on conjugate meningococcal vaccine for serogroups A, C, Y and W135
-
National Advistory Committee on Immunization (NACI)
-
National Advistory Committee on Immunization (NACI). An advisory committee statement (ACS) on conjugate meningococcal vaccine for serogroups A, C, Y and W135. Canada Communicable Disease Report 2007;33(ACS3):1-24.
-
(2007)
Canada Communicable Disease Report
, vol.33
, Issue.ACS3
, pp. 1-24
-
-
-
4
-
-
80051543217
-
Global epidemiology of meningococcal disease
-
Harrison LH, Trotter CL, Ramsay ME. Global epidemiology of meningococcal disease. Vaccine 2009;275:851-63.
-
(2009)
Vaccine
, vol.275
, pp. 851-863
-
-
Harrison, L.H.1
Trotter, C.L.2
Ramsay, M.E.3
-
5
-
-
77953594002
-
The elusive meningococcal meningitis serogroup: A systematic review of serogroup B epidemiology
-
Racloz VN, Luiz SJ. The elusive meningococcal meningitis serogroup: A systematic review of serogroup B epidemiology. BMC Infect Dis 2010;10:175.
-
(2010)
BMC Infect Dis
, vol.10
, pp. 175
-
-
Racloz, V.N.1
Luiz, S.J.2
-
6
-
-
0031752295
-
Population genetics and molecular epidemiology of Neisseria meningitidis
-
Caugant DA. Population genetics and molecular epidemiology of Neisseria meningitidis. APMIS 1998;106:505-25. (Pubitemid 28308237)
-
(1998)
APMIS
, vol.106
, Issue.5
, pp. 505-525
-
-
Caugant, D.A.1
-
7
-
-
84860998698
-
Invasive meningococcal disease in England and Wales: Implications for the introduction of new vaccines
-
Ladhani SN, Flood JS, Ramsay ME, et al. Invasive meningococcal disease in England and Wales: Implications for the introduction of new vaccines. Vaccine 2012;30:3710-6.
-
(2012)
Vaccine
, vol.30
, pp. 3710-3716
-
-
Ladhani, S.N.1
Flood, J.S.2
Ramsay, M.E.3
-
8
-
-
0020518256
-
Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis
-
Finne J, Leinonen M, Makela PH. Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis. Lancet 1983;322:155-7.
-
(1983)
Lancet
, vol.322
, pp. 155-157
-
-
Finne, J.1
Leinonen, M.2
Makela, P.H.3
-
9
-
-
50249119599
-
Genetics and evolution of Neisseria meningitidis: Importance for the epidemiology of meningococcal disease
-
Caugant DA. Genetics and evolution of Neisseria meningitidis: Importance for the epidemiology of meningococcal disease. Infect Gen Evolu 2008;8:558-65.
-
(2008)
Infect Gen Evolu
, vol.8
, pp. 558-565
-
-
Caugant, D.A.1
-
10
-
-
67349185861
-
Meningococcal carriage and disease - Population biology and evolution
-
Caugant DA, Maiden MCJ. Meningococcal carriage and disease - population biology and evolution. Vaccine 2009;27S:B64-B70.
-
(2009)
Vaccine
, vol.27 S
-
-
Caugant, D.A.1
Maiden, M.C.J.2
-
11
-
-
33747182586
-
Invasive meningococcal disease in Quebec, Canada, due to an emerging clone of ST-269 serogroup B meningococci with serotype antigen 17 and serosubtype antigen P1.19 (B:17:P1.19)
-
Law DSK, Lorange M, Ringuette L, et al. Invasive meningococcal disease in Quebec, Canada, due to an emerging clone of ST-269 serogroup B meningococci with serotype antigen 17 and serosubtype antigen P1.19 (B:17:P1.19). J Clin Microbiol 2006;44:2473-9.
-
(2006)
J Clin Microbiol
, vol.44
, pp. 2473-2479
-
-
Law, D.S.K.1
Lorange, M.2
Ringuette, L.3
-
12
-
-
84859972093
-
Invasive serogroup B Neisseria meningitidis in Québec, Canada, 2003-2010: Persistence of the ST-269 clone since it first emerged in 2003
-
Zhou J, Lefebvre B, Deng S, et al. Invasive serogroup B Neisseria meningitidis in Québec, Canada, 2003-2010: Persistence of the ST-269 clone since it first emerged in 2003. J Clin Microbiol 50:1545-51.
-
J Clin Microbiol
, vol.50
, pp. 1545-1551
-
-
Zhou, J.1
Lefebvre, B.2
Deng, S.3
-
13
-
-
79957680694
-
Detection of a geographical and endemic cluster of hyper-invasive meningococcal strains
-
Bertrand S, Van Meerveme E, De Baere T, et al. Detection of a geographical and endemic cluster of hyper-invasive meningococcal strains. Microbes Infect 2011;13:684-90.
-
(2011)
Microbes Infect
, vol.13
, pp. 684-690
-
-
Bertrand, S.1
Van Meerveme, E.2
De Baere, T.3
-
14
-
-
85013713800
-
Community outbreak of group B meningococcal diseasae in southwest France - December 2008 to September 2009
-
Delisle E, Larrieu S, Simoes J, et al. Community outbreak of group B meningococcal diseasae in southwest France - December 2008 to September 2009. Euro Surveill 2010;15:19655.
-
(2010)
Euro Surveill
, vol.15
, pp. 19655
-
-
Delisle, E.1
Larrieu, S.2
Simoes, J.3
-
15
-
-
84880353023
-
Prolonged university outbreak of meningococcal disease associated with a serogroup B strain rarely seen in the U.S.
-
Mandal S, Wu HM, MacNeil JR, et al. Prolonged university outbreak of meningococcal disease associated with a serogroup B strain rarely seen in the U.S. Clin Infect Dis 2013;57:344-8.
-
(2013)
Clin Infect Dis
, vol.57
, pp. 344-348
-
-
Mandal, S.1
Wu, H.M.2
MacNeil, J.R.3
-
16
-
-
84870522017
-
The changing epidemiology of meningococcal disease in Quebec, Canada, 1991-2011: Potential implications of emergence of new strains
-
Gilca R, Deceuninck G, Lefebvre B, et al. The changing epidemiology of meningococcal disease in Quebec, Canada, 1991-2011: Potential implications of emergence of new strains. PLoS One 2012;7:e50659.
-
(2012)
PLoS One
, vol.7
-
-
Gilca, R.1
Deceuninck, G.2
Lefebvre, B.3
-
17
-
-
84872869549
-
First meningitis B vaccine could be available in UK next year
-
Iacobucci G. First meningitis B vaccine could be available in UK next year. Br Med J 2012;345:e7867.
-
(2012)
Br Med J
, vol.345
-
-
Iacobucci, G.1
|